| Literature DB >> 28956823 |
Erin Hoare1, Pia Varsamis2,3, Neville Owen4,5,6, David W Dunstan7,8,9, Garry L Jennings10,11, Bronwyn A Kingwell12,13.
Abstract
Sugar-sweetened beverages (SSBs) are consumed globally, and have been associated with adverse health outcomes, including weight gain, high blood pressure, type 2 diabetes (T2D), and cardiovascular disease (CVD). There is global variation in beverage formulation in terms of glucose and fructose concentration, which may pose unique health risks linked to glycemic control for Australian consumers. However, previous systematic reviews have overlooked Australian-based literature. A systematic review was performed to synthesise evidence for the associations between consumption of SSBs and intense-sweetened beverages with clinical cardiometabolic risk factors in the Australian population. Articles were sourced from Global Health, Health Source: Nursing/Academic Edition, Medline, and Culmative Index to Nursing and Allied Health Literature. To be eligible for review, studies had to report on the consumption of sugar-sweetened (including fruit juice and fruit drinks) and/or intense-sweetened beverages, and at least one clinical cardiometabolic risk factor. Eighteen studies were included in this review. Research has mostly focused on the relationship between SSB consumption and adiposity-related outcomes. No studies have examined indices of glycaemic control (glucose/insulin), and the evidence for the health impact of intense-sweetened drinks is limited. In addition, studies have primarily been of cross-sectional design, and have examined children and adolescents, as opposed to adult populations. In the Australian population, there is modest but consistent evidence that SSB consumption has adverse associations with weight, but there is insufficient data to assess relationships with cardiometabolic outcomes.Entities:
Keywords: cardiometabolic risk factors; glycaemic control; intense-sweetened beverages; sugar-sweetened beverages; systematic review
Mesh:
Substances:
Year: 2017 PMID: 28956823 PMCID: PMC5691692 DOI: 10.3390/nu9101075
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart for article selection following database search.
Clinical cardiometabolic risk factor measured and included covariates.
| Study (Author/Year) | BMI/Overweight/Obesity | Waist Circumference | T2DM | Blood Pressure | Insulin Resistance | Glucose | Glycaemic Index | Triglycerides | Cholesterol | Metabolic Syndrome | Controlled for Physical Activity | Controlled for Diet | Other | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obj | Sub | ||||||||||||||
| Ambrosini et al. (2013) [ | 1433 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ 1 | |||
| Cleland et al. (2008) [ | 2001 | √ | √ 2 | ||||||||||||
| Clifton et al. (2011) [ | 4400 | √ | |||||||||||||
| French et al. (2013) [ | 1015 | √ | |||||||||||||
| Gearon et al. (2013) [ | 30,630 | √ | √ 3 | ||||||||||||
| Grimes et al. (2013) [ | 4283 | √ | √ | √ | √ 4 | ||||||||||
| Hardy et al. (2012) [ | 1568 | √ | |||||||||||||
| Jensen et al. (2013) [ | 1465 | √ | √ 5 | ||||||||||||
| Jones et al. (2016) [ | 1876 | √ | |||||||||||||
| Millar et al. (2014) [ | 4164 | √ | |||||||||||||
| Pase et al. (2015) [ | 160 | √ | √ 6 | ||||||||||||
| Pollard et al. (2016) [ | 13,596 | √ | |||||||||||||
| Sanigorski et al. (2007) [ | 1944 | √ | |||||||||||||
| Sluyter et al. (2013) [ | 1673 | √ | √ 7 | ||||||||||||
| Trapp et al. (2014) [ | 1234 | √ | |||||||||||||
| Thurber et al. (2017) [ | 887 | √ | |||||||||||||
| Wheaton et al. (2015) [ | 4169 | √ | √ 8 | ||||||||||||
| Zheng et al. (2015) [ | 158 | √ | √ | √ 9 | |||||||||||
Obj, objectively measured; Sub, subjectively measured; 1 Adjusted for age, pubertal stage, dietary misreporting, maternal education, and family income. 2 Adjusted for age, education, occupation, and TV viewing time (h). 3 Adjusted for age and smoking status. 4 Adjusted for age, gender, education. 5 Adjusted for age, gender, SES. 6 Adjusted for age, gender, height, weight, mean arterial pressure, heart rate, treatment for lipids and hypertension. 7 Adjusted for SES and “being teased” but were removed when no changes were observed to analyses. 8 Adjusted for gender, age, ethnicity, parental BMI. 9 Adjusted for baseline age, gender, BMI z-score, SES, maternal age at birth, parental education level, presence of gestational diabetes, breastfeeding characteristics, pubertal status.